Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cook Biotech Resolves to Pursue Life Sciences Patent Infringement Case Against ACell Inc.


WEST LAFAYETTE West Lafayette, city (1990 pop. 25,907), Tippecanoe co., W Ind., a suburb of Lafayette, on the Wabash River; inc. 1924. A primarily residential city, it is the seat of Purdue Univ. , Ind. -- The U.S. Court of Appeals for the Federal Circuit recently overturned the verdict reached by a jury in the Federal Court for the Northern District of Indiana concerning biomaterials derived from bladder tissue for use as medical products. The patent at issue is one in a portfolio of patents that protects both breakthrough technology discovered at Purdue University Purdue University (pərdy`, -d`), main campus at West Lafayette, Ind.  and numerous newly-created medical products that are manufactured by Cook Biotech at its facility in the Purdue Research Park Purdue Research Park is a 591-acre research park located in West Lafayette, Indiana, less than 3 miles north of Purdue University's West Lafayette campus. The park is under the continuing development of the Purdue Research Foundation and is currently the largest certified .

"We believe that the Court of Appeals decision is flawed because it reflects a fundamental misunderstanding of the complex anatomy of bladder tissue that is the basis of the patented tissue graft technology," said Mark Bleyer, President of Cook Biotech. "The jury and the district court understood the patented technology and reached the right result. Cook Biotech will pursue correction of the appellate court's decision and will continue to protect its rights to this important technology." Joe Hornett, Senior Vice President/Treasurer & COO of Purdue Research Foundation stated, "Protection of Purdue inventions is one of Purdue Research Foundation's missions, and we support Cook Biotech's continuing efforts."

Cook Biotech Incorporated (www.cookbiotech.com) founded in 1995 with shared ownership by Cook Group, Purdue Research Foundation and Methodist Hospital/Clarian produces tissue-engineered biomaterials and is actively manufacturing and developing extracellular matrix extracellular matrix (eksˈ·tr·selˑ·y  (ECM (1) (Enterprise Change Management) See version control and configuration management.

(2) (Error Correcting Mode) A Group 3 fax capability that can test for errors within a row of pixels and request retransmission.
) technologies for numerous medical purposes. This tissue-engineered biomaterial biomaterial /bio·ma·te·ri·al/ (bi?o-mah-ter´e-al) a synthetic dressing with selective barrier properties, used in the treatment of burns; it consists of a liquid solvent (polyethylene glycol-400) and a powdered polymer.  forms a natural, acellular acellular /acel·lu·lar/ (a-sel´u-ler) not cellular in structure.

a·cel·lu·lar
adj.
1. Containing no cells; not made of cells.

2. Devoid of cells; noncellular.
 scaffold that provides a framework for tissue repair. Cook has developed this ECM technology into a range of medical products used daily by surgeons to help patients around the world.

Purdue Research Foundation (www.purdueresearchpark.com) is responsible for Purdue University's technology-transfer program, the development of Purdue Research Park in West Lafayette, and the management of that park's business development services and flagship incubator.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 28, 2006
Words:297
Previous Article:Waters Corporation Acquires Thermometric(TM) AB.
Next Article:SAVVIS Moves to NASDAQ Global Market Listing.
Topics:



Related Articles
Of judges, genes and genetic engineers: biotech attorneys approach the bench.
The Value of Intellectual Property.
AMGEN EXPECTED TO REPORT DECLINE.
UK COURT RULES AGAINST AMGEN RIVAL CAN MAKE OWN ANEMIA DRUG.
Jury finds for Cadence in patent suit: mentor to challenge rulings. (Design).
Another patent lawsuit hits Hynix.
TechMedia launches "TechJournal South".

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles